Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rault

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Clinical Nephrology|November 1, 1991
Iatrogenic hypercalcemia in hemodialysis patientsM A Muhammedi, B Piraino, R Rault, et al.
Clinical Pharmacology and Therapeutics|September 1, 1984
Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentrationP D Kroboth, R B Smith, M I Sorkin, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of end-stage renal disease and aluminum hydroxide on temazepam kineticsP D Kroboth, R B Smith, R Rault, et al.
British Journal of Clinical Pharmacology|June 1, 1985
Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokineticsP D Kroboth, R B Smith, M R Silver, et al.
The American Journal of Medicine|April 1, 1986
Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerationsB M Piraino, R Rault, A Greenberg, et al.
Journal of the National Cancer Institute|June 3, 1992
Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changesJ B Ochoa, B Curti, A B Peitzman, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Clinical Nephrology|November 1, 1991
Iatrogenic hypercalcemia in hemodialysis patientsM A Muhammedi, B Piraino, R Rault, et al.
Clinical Pharmacology and Therapeutics|September 1, 1984
Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentrationP D Kroboth, R B Smith, M I Sorkin, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of end-stage renal disease and aluminum hydroxide on temazepam kineticsP D Kroboth, R B Smith, R Rault, et al.
British Journal of Clinical Pharmacology|June 1, 1985
Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokineticsP D Kroboth, R B Smith, M R Silver, et al.
The American Journal of Medicine|April 1, 1986
Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerationsB M Piraino, R Rault, A Greenberg, et al.
Journal of the National Cancer Institute|June 3, 1992
Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changesJ B Ochoa, B Curti, A B Peitzman, et al.
Pageof 4